sanegenebio
SanegeneBio is a clinical-stage biotechnology company developing RNAi (RNA interference) genetic medicines for metabolic, cardiovascular, and complement-mediated autoimmune diseases, including obesity. Its proprietary LEAD (Ligand and Enhancer Assisted Delivery) platform enables receptor-mediated, targeted delivery of siRNA therapeutics to adipocytes, skeletal myocytes, and other tissues beyond the liver. The company operates as a fully integrated global biotech and has raised over $150 million to advance its pipeline. Surfaced as a portfolio company of Qiming and added to the API Evangelist network; it publishes a corporate website (about, technology, pipeline, news, contact) but no public developer, API, or documentation surface at this time.
sanegenebio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Genetic Medicine, RNAi, and Therapeutics.
sanegenebio’s developer surface includes engineering blog, support, and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API